Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

被引：0
|
作者：
S Diem
B Kasenda
L Spain
J Martin-Liberal
R Marconcini
M Gore
J Larkin
机构：
[1] Royal Marsden Hospital NHS Foundation Trust,Department of Medical Oncology
[2] Vall d’Hebron University Hospital,Department of Medical Oncology
[3] Vall d’Hebron Institute of Oncology (VHIO),Department of Medical Oncology
[4] Santa Chiara Hospital,undefined
来源：
British Journal of Cancer | 2016年 / 114卷
关键词：
melanoma; anti-PD-1; lactate dehydrogenase; marker; response; survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：256 / 261
页数：5
相关论文
共 50 条
  • [41] Patterns of acquired resistance to anti-PD-1 antibodies in patients with metastatic melanoma (MM).
    Lee, Jenny H. J.
    Cooper, Adam James
    Lyle, Megan Kate
    Liniker, Elizabeth
    Menzies, Alexander M.
    Kefford, Richard
    Long, Georgina V.
    Carlino, Matteo S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy
    Kim, Isaac
    Rajamanickam, Venkatesh
    Bernard, Brady
    Chun, Brie
    Wu, Yaping
    Martel, Maritza
    Sun, Zhaoyu
    Redmond, William L.
    Sanchez, Katherine
    Basho, Reva
    McArthur, Heather
    Page, David B.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Major pathologic response on biopsy (MPRbx) in patients with melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response
    Stein, Julie E.
    Soni, Abha
    Danilova, Ludmila
    Cottrell, Tricia R.
    Sharfman, William H.
    Wind-Rotolo, Megan
    Edwards, Robin
    Lipson, Evan J.
    Taube, Janis M.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [44] Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
    Rossi, Ernesto
    Cellini, Francesco
    Pagliara, Monica Maria
    Sammarco, Maria Grazia
    Pedone, Romina Rose
    Lancellotta, Valentina
    Tagliaferri, Luca
    Quirino, Michela
    Gambacorta, Maria Antonietta
    Blasi, Maria Antonietta
    Tortora, Giampaolo
    Schinzari, Giovanni
    [J]. CANCERS, 2023, 15 (02)
  • [45] What to Do When Anti-PD-1 Therapy Fails in Patients With Melanoma
    Mooradian, Meghan J.
    Sullivan, Ryan J.
    [J]. ONCOLOGY-NEW YORK, 2019, 33 (04): : 141 - 148
  • [46] Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy
    de With, Mirjam
    Hurkmans, Daan P.
    Oomen-de Hoop, Esther
    Lalouti, Ayoub
    Bins, Sander
    El Bouazzaoui, Samira
    van Brakel, Mandy
    Debets, Reno
    Aerts, Joachim G. J. V.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    van der Veldt, Astrid A. M.
    [J]. CANCERS, 2021, 13 (06) : 1 - 13
  • [47] Total RNA-transcriptomics for identification of predictors of overall survival in metastatic melanoma patients treated with anti-PD-1
    Xiao, Qingyang
    Oliver, Javier
    Luis Onieva, Juan
    Pineiro, Pilar
    Garrido-Aranda, Alicia
    Laborda-Illanes, Aurora
    Gallego, Elena
    Robles-Podadera, Cynthia
    Chica-Parrado, Rosario
    Prieto, Daniel
    Sanchez, Alfonso
    De Luque, Vanessa
    Jose Lozano, Maria
    Alvarez, Martina
    Jimenez, Pedro
    Alba, Emilio
    Berciano-Guerrero, Miguel
    Cobo, Manuel
    Barragan, Isabel
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [48] Excellent response to anti-PD-1 therapy in a patient with metastatic malignant melanoma: case report
    Silvestri, Antonia
    Specchia, Monica
    Musacchio, Michela
    Giglio, Gianfranco
    Carrozza, Francesco
    Di Lullo, Liberato
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [49] Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
    Afzal, Muhammad Zubair
    Mabaera, Rodwell
    Shirai, Keisuke
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [50] PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH ANTI-PD-1 THERAPY - THE MELIMMUNE SCORE
    Lobo-Martins, Soraia
    Martins-Branco, Diogo
    Semedo, Patricia Miguel
    Alvim, Cecilia Melo
    Monteiro, Ana Maria
    Vendrell, Ines
    Gouveia, Emanuel
    Passos, Maria Jose
    Costa, Luis
    Mansinho, Andre
    de Sousa, Rita Teixeira
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A4 - A4
12345